|
TYW1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12240003349962E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.97839999996441E-07 |
| Normal-vs-Stage2 |
3.057900E-02 |
| Normal-vs-Stage3 |
8.685700E-02 |
| Normal-vs-Stage4 |
2.456300E-02 |
| Stage1-vs-Stage2 |
5.852600E-01 |
| Stage1-vs-Stage3 |
1.033000E-01 |
| Stage1-vs-Stage4 |
9.120200E-01 |
| Stage2-vs-Stage3 |
4.099400E-01 |
| Stage2-vs-Stage4 |
7.680600E-01 |
| Stage3-vs-Stage4 |
2.838000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17079995593161E-09 |
| Normal-vs-AfricanAmerican |
2.568400E-04 |
| Normal-vs-Asian |
2.748800E-01 |
| Caucasian-vs-AfricanAmerican |
2.675600E-01 |
| Caucasian-vs-Asian |
7.501200E-01 |
| AfricanAmerican-vs-Asian |
9.473200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16799999672068E-08 |
| Normal-vs-Female |
3.12469999996789E-06 |
| Male-vs-Female |
5.158800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.962610E-03 |
| Normal-vs-Extreme_Weight |
2.25010000000081E-05 |
| Normal-vs-Obese |
5.97360000020863E-07 |
| Normal-vs-Extreme_Obese |
1.866230E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.710800E-01 |
| Normal_Weight-vs-Obese |
7.176800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.450000E-01 |
| Extreme_Weight-vs-Obese |
9.567000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.215600E-01 |
| Obese-vs-Extreme_Obese |
4.867800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.19189999999259E-05 |
| Normal-vs-Age(41-60Yrs) |
1.36199995726116E-09 |
| Normal-vs-Age(61-80Yrs) |
4.65780000002969E-06 |
| Normal-vs-Age(81-100Yrs) |
2.020200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.869800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.975600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.289200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.710260E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.569400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.133200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82276416182958E-12 |
| Normal-VS-Type2 PRCC |
1.104770E-01 |
| Normal-VS-KIRP CIMP |
6.623900E-02 |
| Normal-VS-Unclassified PRCC |
1.694340E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.06939999966471E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.633840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.764280E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.089200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.446830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.889000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009790E-02 |
| Normal-vs-N1 |
3.113700E-02 |
| Normal-vs-N2 |
7.643800E-03 |
| N0-vs-N1 |
9.286200E-01 |
| N0-vs-N2 |
4.634600E-01 |
| N1-vs-N2 |
4.629200E-01 |
|
|
